| ★ | What Does New Phase 3 Amlitelimab Data Suggest for Atopic Dermatitis? | | 92 | Estados Unidos | |
| 13 | Ralinepag Cuts PAH Clinical Worsening Risk by 55%, With Vallerie McLaughlin, MD | ATS 2026 | | 290 | Estados Unidos | 64 |
| 16 | Why Fewer Than Half of Referred Patients Reach Kidney Transplant Evaluation | | 217 | Estados Unidos | 63 |
| 6 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 65 |
| 19 | New Martin-Hopkins LDL-C-Estimating Equation Simplifies Implementation for Comparable Results | | 151 | Estados Unidos | 62 |
| 2 | How Are New Biologics Changing Atopic Dermatitis Treatment? | | 137 | Estados Unidos | 69 |
| 11 | Key Off-Label Treatment Options in Dermatology, With Matthew Zirwas, MD | | 117 | Estados Unidos | 65 |
| 7 | AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD | | 105 | Estados Unidos | 65 |
| 1 | What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis? | | 91 | Estados Unidos | 72 |
| 20 | ADorable-1 Results: Key Findings in Pediatric Atopic Dermatitis | | 58 | Estados Unidos | 62 |
| 8 | What Factors Should Guide Atopic Dermatitis Treatment Selection? With Walter Liszewski, MD | | 46 | Estados Unidos | 65 |
| 14 | Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA | | 30 | Estados Unidos | 64 |
| 4 | Is Atopic Dermatitis Due to Environment or Genetics? With Matthew Zirwas, MD | | 23 | Estados Unidos | 68 |
| 9 | What Are the Lasting Consequences of Childhood-Onset Atopic Dermatitis? | | 23 | Estados Unidos | 65 |
| 5 | Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD | | 21 | Estados Unidos | 66 |
| 3 | Are You Misdiagnosing Atopic Dermatitis? Matthew Zirwas, MD, on Adult-Onset AD | | 19 | Estados Unidos | 68 |
| 17 | How ABCG2 Inhibition Could Change EPP Disease Management | | 17 | Estados Unidos | 63 |
| 10 | What Are Some Clinical Pearls in Pediatric Dermatology? With Lisa Swanson, MD | | 16 | Estados Unidos | 65 |
| 15 | How Should Clinicians Address the Link Between Atopic Dermatitis and Allergy? With Jay Lieberman, MD | | 13 | Estados Unidos | 64 |
| 12 | What's Next for Peanut Allergy Microneedle Immunotherapy, With Brian Vickery, MD | | 12 | Estados Unidos | 64 |
| 18 | How Are Career and Education Opportunities Impacted by Atopic Dermatitis? | | 9 | Estados Unidos | 63 |